Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This discussion is centered on surveys recently done on accessibility to anti-malarial drugs globally and artemisinin-based combination therapies (ACTs). ACTs which have been highly effective are recommended treatment for malaria but despite free or highly subsidised public sector provision, access is still poor. Catherine Goodman discusses survey results on uptake, accessibility, pricing, subsidies, supply chains and supporting interventions to ensure effective ACT scale-up. These surveys were conducted by the global fund and Bill & Melinda Gates Foundation through its support to the ACT watch project

Dr Catherine Goodman works as a health economist at the London School of Hygiene & Tropical Medicine. Dr Goodman's research focuses on access to malaria treatment and health systems.

Crossing boundaries 2014

Africa – Oxford health systems research collaboration

Researchers from Europe and Africa gathered in Oxford on the 27th and 28th February 2014 to share knowledge on health systems research, economics and governance in health management.